TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name Hyperoside
PubChem CID 5281643
Molecular Weight 464.4g/mol
Synonyms

hyperin, hyperoside, quercetin galactoside, quercetin-3-O-galactoside

Formula C₂₁H₂₀O₁₂
SMILES C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O
InChI 1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15+,17+,18-,21+/m1/s1
InChIKey OVSQVDMCBVZWGM-DTGCRPNFSA-N
CAS Number 482-36-0
ChEMBL ID CHEMBL251254
ChEBI ID CHEBI:67486
Herb ID HBIN029837
Drug Bank ID DB16403
KEGG ID C10073
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
(1) Nelumbo nucifera Even
Chineses Pinyin HeYe
Use Part Leaf
Habitat China
Flavor Bitter
Meridian Tropism Liver, Spleen, Stomach
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Proteales
    -->Family: Nelumbonaceae
     -->Genus: Nelumbo
      -->Species: Nelumbo nucifera
(2) Hypericum monogynum Cool
Chineses Pinyin JinSiTao
Use Part Root; Stem; Leaf; Flowers; Fruit
Flavor Pungent
Meridian Tropism Liver
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Malpighiales
    -->Family: Hypericaceae
     -->Genus: Hypericum
      -->Species: Hypericum monogynum
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose efficacy can be enhanced by this phytochemical
Hide/Show
Combination Pair ID: 88
Pair Name Hyperoside, Paclitaxel
Partner Name Paclitaxel
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Activity CASP3 hsa836
Up-regulation Expression IL6 hsa3569
Down-regulation Expression RELA hsa5970
Down-regulation Activity TLR4 hsa7099
In Vitro Model MDA-MB-231 Breast adenocarcinoma Homo sapiens (Human) CVCL_0062
HCC1806 Breast squamous cell carcinoma, acantholytic variant Homo sapiens (Human) CVCL_1258
Result Hyperoside may elevate breast cancer cell sensitivity to paclitaxel by blocking TLR4 activation-mediated pro-inflammatory and pro-survival approaches, thereby endorsing its usefulness as a promising therapeutic combination to overcome chemosensitivity in breast cancer.
04. Reference
No. Title Href
1 Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling. Mol Cell Probes. 2020 Oct;53:101602. doi: 10.1016/j.mcp.2020.101602. Click
It has been 46581 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP